Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care

Hormones

Volumn 12, Issue 3, 2013, Pages 428-438

  Banach, Rita ^a   Bartès, Beate ^b   Farnell, Kate ^c   Rimmele, Harald ^d   Shey, Joan ^e   Singer, Susanne ^f   Verburg, Frederik A ^g   Luster, Markus ^h  

^a Thyroid Cancer Canada Cancer de la thyroïde Canada   (Canada)

^b Vivre sans Thyroide   (France)

^c Butterfly Thyroid Cancer Trust   (United Kingdom)

^d Bundesverband Schilddrüsenkrebs Ohne S childdrüse leben e V   (Germany)

^e Light of Life Foundation   (United States)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^h UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Hypothyroidism; International variation in treatment practices; Patient organizations; Patient support needs; Patient survey; Recombinant human TSH; Surgical complications; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVOR; DEPRESSION; DIFFERENTIATED THYROID CANCER; DIZZINESS; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; HYPOCALCEMIA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEEDS ASSESSMENT; PARESTHESIA; PATIENT CARE; PATIENT INFORMATION; PATIENT REFERRAL; PSYCHOSOCIAL CARE; SALIVARY GLAND PAIN; SIALOADENITIS; SIDE EFFECT; TASTE DISORDER; THINKING; THYROID CANCER; THYROID SURGERY; VOICE DISORDER; VOMITING; XEROSTOMIA;

ADULT; CANADA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; SURVIVORS; THYROID NEOPLASMS; THYROIDECTOMY; UNITED STATES;

EID: 84885215283     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401308     Document Type: Article

References (26)

1. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV, 2011 Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol (Oxf) 75: 544-554.
2. Pitoia F, Licht S, 2007 Evaluation of the effect of thyroid hormone withdrawal on the quality of life of patients with differentiated thyroid carcinoma (in Spanish). Glánd Tir Paratir 16: 25-29.
3. Larisch R, Kley K, Nikolaus S, et al, 2004 Depression and anxiety in different thyroid function states. Horm Metab Res 36: 650-653.
4. Tagay S, Herpertz S, Langkafel M, et al, 2005 Healthrelated quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol 153: 755-763.
5. Tagay S, Herpertz S, Langkafel M, et al, 2006 Healthrelated quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15: 695-703.
6. Freyer G, Dazord A, Schlumberger M, et al, 1999 Psychosocial impact of genetic testing in familial medullarythyroid carcinoma: a multicentric pilot-evaluation. Ann Oncol 10: 87-95.
7. Hirsch D, Ginat M, Levy S, et al, 2009 Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid 19: 459-465.
8. Dow KH, Ferrell BR, Anello C, 1997 Balancing demands of cancer surveillance among survivors of thyroid cancer. Cancer Pract 5: 289-295.
9. Stajduhar KI, Neithercut J, Chu E, et al, 2000 Thyroid cancer: patients' experiences of receiving iodine-131 therapy. Oncol Nurs Forum 27: 1213-1218.
10. McGrath PN, Fitch MI, 2003 Patient perspectives on the impact of receiving radioactive iodine: implications for practice. Can Oncol Nurs J 13: 152-163.
11. Sawka AM, Goldstein DP, Brierley JD, et al, 2009 The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS ONE 4: e4191.
12. Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW, 2008 Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93: 200-203.
13. Shey J, 2001 Why I started the Thyroid Cancer Foundation. Cancer 91: 623-624.
14. Farnell K, 2010 Personal view. Thyroid cancer: doctorpatient partnership. Clin Oncol (R Coll Radiol) 22: 512-513.
15. Singer S, Hohlfeld S, Müller-Briel D, et al, 2011 Psychosocial care for cancer patients. Care provided and requirements. Psychotherapeut 56: 386-393.
16. Federation of International Pyscho-Oncology Societies, 2012 Psychosocial care in cancer care: situation in the countries represented within the Federation of Psycho-Oncology Societies. Psycho-Oncology, in press.
17. Van Nostrand D, Wartofsky L, Bloom G, Kulkarni KP (eds) 2010 Thyroid cancer: A guide for patients, second edition, Keystone Press, Pasadena, MD, USA; pp. 1-434.
18. Luster M, Felbinger R, Dietlein M, Reiners C, 2005 Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration. Thyroid 15: 1147-1155.
19. Schroeder PR, Haugen BR, Pacini F, et al, 2006 A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 91: 878-884.
20. Dow KH, Ferrell BR, Anello C, 1997 Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7: 613-619.
21. Pacini F, Ladenson PW, Schlumberger M, et al, 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91: 926-932.
22. Haugen BR, Pacini F, Reiners C, et al, 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84: 3877-3885.
23. Mendoza A, Shaffer B, Karakla D, Mason ME, Elkins D, Goffman TE, 2004 Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid 14: 133-140.
24. Thomusch O, Machens A, Sekulla C, et al, 2000 Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24: 1335-1341.
25. Sherman SI, Brierley JD, Sperling M, et al, 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83: 1012-1021.
26. Dietlein M, Verburg FA, Luster M, Reiners C, Pitoia F, Schicha H, 2011 One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 38: 793-798.